MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E

Autres langues Macro Group Pharmaceuticals (Macro Capital) S.A.E

Actions

MCRO

EGS7D971C011

Produits pharmaceutiques

Cours en clôture Egyptian Exchange Autres places de cotation 26/07/2026			Varia. 5j.	Varia. 1 janv.
1,520 ^EGP	+4,11%		+12,59%	+33,33%

17/05	Macro Group Pharmaceutical : bénéfice net consolidé de 33,3 millions d'EGP au premier trimestre	RE
19/02	Macro Group Pharmaceuticals (Macro Capital) S.A.E publie ses résultats financiers pour l'exercice clos le 31 décembre 2025	CI

Autres langues

17/05	Macro Group Pharmaceutical Q1 consol profit egp 33.3 million
19/02	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025
19/02	Macro Group Pharmaceutical FY consol profit EGP 115.7 mln
19/11	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
13/11	Macro Group Pharmaceutical nine-month consol loss EGP 66.1 million
12/10/25	Macro Group Pharmaceutical shareholders approve authorized capital increase to EGP 3 billion
21/08/25	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
21/08/25	Macro Group Pharmaceutical posts Q2 consol profit EGP 46.5 mln
21/08/25	Macro Group Pharmaceutical board approves renewal of EGP 100 mln short-term financing from KFH
22/07/25	Macro Group Pharmaceutical board proposes capital increase
10/06/25	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2025
10/04/25	MACRO Group Pharmaceutical's 328.6 Million Shares Block Traded For EGP 631 Million - EGX
26/02/25	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2024
26/02/25	MACRO Group Pharmaceutical FY Consol Loss At 38.1 Million
12/11/24	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
04/09/24	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
30/07/24	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2024
16/04/24	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023
15/11/23	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
17/05/23	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023
29/03/23	Rimco EGT Investment acquired 3.2% stake in Macro Group Pharmaceutical for EGP 61.5 million.
02/03/23	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2022
05/11/22	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
29/05/22	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2022
07/03/22	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2021